Daniel Carlat, MD

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

PDF/eBook with CME Post-Test Access

January 1, 2022

Chris Aiken, MD, Joshua Feder, MD, and Daniel Carlat, MD

Dr. Aiken, Dr. Feder, and Dr. Carlat have no relevant financial relationship(s) with ineligible companies to disclose.

This page has links and instructions for taking the 10 CME post-test for Prescribing Psychotropics (2022) and downloading your PDF and eBook copies.

Prescribing Psychotropics: From Drug Interactions to Pharmacogenetics (2022)

PDF/eBook Access and CME Post-Test

January 1, 2022

Chris Aiken, MD, Joshua Feder, MD, and Daniel Carlat, MD

Dr. Aiken, Dr. Feder, and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity. have no relevant financial relationship(s) with ineligible companies to disclose.

This page has links and instructions for taking the 10 CME post-test for Prescribing Psychotropics (2022) and downloading your PDF and eBook copies.

Medications to Rapidly Treat Psychotic Agitation

September 13, 2021

Daniel Carlat, MD

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.

Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

How do you choose medications to calm an acutely psychotic and agitated patient? We'll tell you which ones are the safest and most effective.

IM Olanzapine Plus Benzodiazepines: Safe or Unsafe?

September 13, 2021

Daniel Carlat, MD

Victoria Hendrick, MD. Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report.

Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If you have ever tried to electronically prescribe IM olanzapine with an IM/IV/subcutaneous benzodiazepine, you have probably received an interaction alert warning about the potential for excessive sedation and cardiorespiratory depression. Is this warning justified? Let’s look at the data.

Intranasal Esketamine: New Hope for Suicidal Patients?

April 12, 2021

Daniel Carlat, MD

Victoria Hendrick, MD.

Editor in Chief, The Carlat Hospital Psychiatry Report. Chief, Inpatient Psychiatry, Olive View UCLA Medical Center.

Daniel Carlat, MD. Publisher, The Carlat Hospital Psychiatry Report. Dr. Hendrick and Dr. Carlat have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment.

Non-Addictive, Pharmacological Options for Sleep

August 23, 2018

Daniel Carlat, MD

Daniel Carlat, MD Publisher, The Carlat Addiction Treatment Report Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

In this month’s interview with Dr. Eric Hermes, we learned about his approach to treating insomnia in patients with substance use disorders, with a focus on cognitive behavioral therapy. In this article, we’ll look at some non-addictive pharmacological options.

Note From the Editor-in-Chief

March 1, 2018

Daniel Carlat, MD

Daniel Carlat, MD Editor-in-Chief, The Carlat Psychiatry Report

We publish an issue on antipsychotics at least once a year, and it’s always a challenge to decide what to cover. There are dozens of antipsychotics, and most of them are approved for mood disorders as well as psychosis.

Medication Fact Book For Psychiatric Practice, Fourth Edition (2018)

PDF Access and CME Post-Test

February 28, 2018

Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have disclosed that they has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Downloading your PDF and eBook copies and complete the CME Post-Test for The Medication Fact Book for Psychiatric Practice, Fourth Edition (2018).

Note From the Editor-in-Chief

February 1, 2018

Daniel Carlat, MD

Daniel Carlat, MD Editor-in-Chief, The Carlat Psychiatry Report

For this month’s issue, I asked two experts in family and couples therapy to remind us of how crucial it is to communicate with family members of patients. In the rush of a clinical day, it’s often easiest to simply deal with whomever shows up to the appointment—typically just the patient.

Note From the Editor-in-Chief

January 1, 2018

Daniel Carlat, MD

Daniel Carlat, MD Editor-in-Chief, The Carlat Psychiatry Report

When I was training in the 1990s, diagnosing bipolar disorder seemed straightforward. These patients often came to our attention because of a flagrant manic episode. You may still remember the first time you treated a manic patient—I certainly do.